Evaluation of SLC6A2 and CYP2D6 polymorphisms' effects on atomoxetine treatment in attention deficit and hyperactivity disorder.

Kole I. H., Vural P., Yurdacan B., Alemdar A., Mutlu C.

European journal of clinical pharmacology, cilt.80, sa.11, ss.1773-1785, 2024 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 80 Sayı: 11
• Basım Tarihi: 2024
• Doi Numarası: 10.1007/s00228-024-03744-z
• Dergi Adı: European journal of clinical pharmacology
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, CAB Abstracts, Chimica, CINAHL, EMBASE
• Sayfa Sayıları: ss.1773-1785
• Anahtar Kelimeler: Atomoxetine, Attention deficit and hyperactivity disorder, CYP2D6, Genetic polymorphism, SLC6A2
• Erzincan Binali Yıldırım Üniversitesi Adresli: Evet